BASS XIV Presentations

Session	Speaker	Presentation
M-1	Mike Davenport	An Adaptive Dose Finding Design (DOSEFIND): Using a Nonlinear Dose Response Model
M-2	Susan Willavize	Dose Response Modeling for Combination Drug Products
M-3	Neal Thomas	Bayesian Analysis of Dose Response
M-4	Jason Liao	Concordance Analysis in the Biopharmaceutical Industry
M-5	Yongming Qu	Surrogate Markers Validation: What Should be Considered?
M-6	Jack Ostroff	An Introduction to Pathodynamics from the View of Liver Homeostasis Using the Ornstein-Uhlenbeck Process
M-7	Jonathan Schildcrout	On the Analysis of Longitudinal Clinical Lab Data with Latent Mixture Models
M-8	Karl Peace	Some Thoughts on the Assessment of Pharmaceutical Safety Data
M-8	Michael O'Connell	Statistical Modeling and Graphical Analysis of Safety Data in Clinical Trials
Keynote Address	Mitch Gail	Absolute Risk: Clinical Applications and Controversies
T-1	Vlad Dragalin	Adaptive Model-Based Designs in Clinical Drug Development
T-2	Quan Hong	A New Method for Steady State Assessment Based on Nonlinear Mixed Effect Modeling
T-4	Robb Muirhead	Moving Beyond QT in Assessing the Arrhythmic Liability of Drugs
T-5	Anthony Segreti	Strategies for Meta-Analyses of Randomized Clinical Trials Based on Individual Patient Data
T-6	Edit Kurali	Statistical Issues in Predictive Toxicology
W-FDA	Guoxing (Greg) Soon	Handling Missing Data in Clinical Trials - Design and Analysis Issues with Examples from Anti-viral Area
W-FDA	Mohamed Alosh	Analysis of Longitudinal Count Data with Possibility of Dropouts
W-FDA	Thamban Valappil	An Overview of Causal Inference and its Applications in Clinical Trials
W-FDA	Adam Meyers	Developing an Analytic Road Map for Incomplete Longitudinal Clinical Trial Data